{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: Thailand Biotechnology news", "home_page_url": "https://sharemaestro.com/newsreel/th/healthcare/biotechnology/", "feed_url": "https://sharemaestro.com/newsreel/th/healthcare/biotechnology/feed.json", "description": "Latest Biotechnology company headlines from Thailand, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:742d93d2de82b033d7073101f125b70d70e379510fa91e67ca92a4984ff3539a", "url": "https://finance.yahoo.com/healthcare/articles/wuxi-biologics-recognized-industry-top-070400868.html", "external_url": "https://finance.yahoo.com/healthcare/articles/wuxi-biologics-recognized-industry-top-070400868.html", "title": "WuXi Biologics Recognized for Industry Top Sustainable Biopharma Practices Empowering the Industry's Transformation Through Green CRDMO", "content_text": "SHANGHAI, Aug. 18, 2026 /PRNewswire/ -- BioPharma APAC recently published its Top 26 - Companies Leading Sustainable Biopharma Practices in 2026, highlighting leading sustainability practices across pharmaceutical companies, biotechnology firms and CRDMOs in Europe, North America and Asia Pacific, with a focus on Science Based Targets initiative (SBTi) commitments, value-chain decarbonization, green manufacturing, and sustainable operations. The list brings together global pharmaceutical leaders \u2013 such as MSD (Merck & Co.), Eli Lilly, Johnson & Johnson, AstraZeneca, Takeda, GSK and Bayer \u2013 col", "date_published": "2026-08-18T07:04:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "WUXI13"], "_sharemaestro": {"country": "Thailand", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "WUXI13", "name": "WuXi Biologics (Cayman) Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/019ee3ff-0322-4dbf-b92a-a33a1cb24ea9/"}]}}]}